Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Breast Cancer
-
-
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
-
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
-
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
-
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831
-
Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer
-
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
-
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
-
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial
-
Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer